Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ear discharge treatment study in children
ISRCTN22413988Phase 3Not yet recruiting
- Sponsor
- Manchester University NHS Foundation Trust
- Start
- Nov 2026
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
01
Overview
Phase 3, randomised, open-label trial of ciprofloxacin, amoxicillin and clarithromycin in acute otitis media (AOM) (2 arms), sponsored by Manchester University NHS Foundation Trust. Primary endpoints: Number of patients referred to the study during recruitment, Time from referral to remote consultation with research doctor and 6 more. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
ciprofloxacinamoxicillinclarithromycin
03
Conditions
acute otitis media (AOM)
Beyond the preview
Go deeper on ISRCTN22413988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN22413988.